Seelos Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Dec 23 | BuyUS$99,999 | Raj Mehra | Individual | 591.85 | US$168.96 | |
30 Nov 23 | BuyUS$100,223 | Michael Golembiewski | Individual | 648.44 | US$154.56 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 2,135 | 0.49% |
Institutions | 44,955 | 10.3% |
General Public | 388,868 | 89.2% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 937.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
18,113 | US$9.0k | 223% | no data | |||
10,805 | US$5.3k | 711% | no data | |||
8,477 | US$4.2k | 282,000% | no data | |||
4,085 | US$2.0k | 492% | 0.01% | |||
2,194 | US$1.1k | 0% | no data | |||
1,446 | US$715.8 | 0% | no data | |||
679 | US$336.1 | 0% | no data | |||
675 | US$334.1 | -51.5% | no data | |||
354 | US$175.2 | -18.6% | no data | |||
95 | US$47.0 | -60.6% | no data | |||
62 | US$30.7 | 0% | no data | |||
32 | US$15.8 | 10.3% | no data | |||
31 | US$15.3 | 0% | no data | |||
12 | US$5.9 | -7.69% | no data | |||
9 | US$4.4 | 0% | no data | |||
7 | US$3.5 | 0% | no data | |||
7 | US$3.5 | 0% | no data | |||
2 | US$1.0 | 0% | no data | |||
1 | US$0.5 | 0% | no data | |||
1 | US$0.5 | 0% | no data | |||
1 | US$0.5 | 0% | no data | |||
1 | US$0.5 | 0% | no data | |||
1 | US$0.5 | 0% | no data |